Liver argininosuccinate synthase binds to bacterial lipopolysaccharides and lipid A and inactivates their biological activities

M. Satoh, Tsuguya Iwahori, N. Sugawara, M. Yamazaki
{"title":"Liver argininosuccinate synthase binds to bacterial lipopolysaccharides and lipid A and inactivates their biological activities","authors":"M. Satoh, Tsuguya Iwahori, N. Sugawara, M. Yamazaki","doi":"10.1177/09680519060120010301","DOIUrl":null,"url":null,"abstract":"The liver is known to clear and detoxify circulating lipopolysaccharide (LPS). To characterize the molecules involved in this process in the liver, we attempted to purify mouse liver protein(s) that can interact with lipid A, a biologically active portion of LPS. By partially purifying the inactivating activity against a synthetic lipid A analog, we observed the enrichment of a 45-kDa protein in the active fractions. The internal amino acid sequences of the protein were identical with those of argininosuccinate synthase (EC 6.3.4.5). To examine whether argininosuccinate synthase can interact with lipid A, we purified the enzyme from mouse liver and found the co-elevation of the specific enzyme activity and specific lipid A-inactivating activity, indicating that argininosuccinate synthase is the major lipid A-interacting protein in liver. Argininosuccinate synthase also inhibited the biological activities (macrophage activation and Limulus test) of natural lipid A and rough-type LPS but not smooth-type LPS. The enzyme activity was inhibited by lipid A and rough-type LPS and also by smooth-type LPS. Native gel electrophoresis of a mixture of argininosuccinate synthase and LPS and immunoprecipitation of a mixture of argininosuccinate synthase and [3H]-LPS with anti-argininosuccinate synthase antiserum showed that argininosuccinate synthase stably bound lipid A and LPS. These findings, together, indicate that argininosuccinate synthase can effectively bind LPS in the liver.","PeriodicalId":80292,"journal":{"name":"Journal of endotoxin research","volume":"12 1","pages":"21 - 38"},"PeriodicalIF":0.0000,"publicationDate":"2006-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/09680519060120010301","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of endotoxin research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/09680519060120010301","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16

Abstract

The liver is known to clear and detoxify circulating lipopolysaccharide (LPS). To characterize the molecules involved in this process in the liver, we attempted to purify mouse liver protein(s) that can interact with lipid A, a biologically active portion of LPS. By partially purifying the inactivating activity against a synthetic lipid A analog, we observed the enrichment of a 45-kDa protein in the active fractions. The internal amino acid sequences of the protein were identical with those of argininosuccinate synthase (EC 6.3.4.5). To examine whether argininosuccinate synthase can interact with lipid A, we purified the enzyme from mouse liver and found the co-elevation of the specific enzyme activity and specific lipid A-inactivating activity, indicating that argininosuccinate synthase is the major lipid A-interacting protein in liver. Argininosuccinate synthase also inhibited the biological activities (macrophage activation and Limulus test) of natural lipid A and rough-type LPS but not smooth-type LPS. The enzyme activity was inhibited by lipid A and rough-type LPS and also by smooth-type LPS. Native gel electrophoresis of a mixture of argininosuccinate synthase and LPS and immunoprecipitation of a mixture of argininosuccinate synthase and [3H]-LPS with anti-argininosuccinate synthase antiserum showed that argininosuccinate synthase stably bound lipid A and LPS. These findings, together, indicate that argininosuccinate synthase can effectively bind LPS in the liver.
肝精氨酸琥珀酸合成酶与细菌脂多糖和脂质A结合并使其生物活性失活
众所周知,肝脏可以清除和解毒循环中的脂多糖(LPS)。为了表征肝脏中参与这一过程的分子,我们试图纯化可以与脂质A (LPS的生物活性部分)相互作用的小鼠肝脏蛋白。通过部分纯化对合成脂质a类似物的失活活性,我们观察到活性部分富集了45 kda的蛋白质。该蛋白的内部氨基酸序列与精氨酸琥珀酸合成酶(EC 6.3.4.5)相同。为了研究精氨酸琥珀酸合酶是否能与脂质A相互作用,我们从小鼠肝脏中纯化了该酶,发现其特异性酶活性与特异性脂质A失活活性共同升高,表明精氨酸琥珀酸合酶是肝脏中主要的脂质A相互作用蛋白。精氨酸琥珀酸合酶对天然脂质A和粗糙型LPS的生物活性(巨噬细胞活化和鲎试验)也有抑制作用,但对光滑型LPS无抑制作用。脂质A和粗糙型LPS对酶活性有抑制作用,光滑型LPS对酶活性也有抑制作用。精氨酸琥珀酸合成酶与LPS的天然凝胶电泳和精氨酸琥珀酸合成酶与[3H]-LPS与抗精氨酸琥珀酸合成酶抗血清的混合免疫沉淀表明,精氨酸琥珀酸合成酶稳定结合脂质a和LPS。综上所述,精氨酸琥珀酸合酶可以有效地结合肝脏中的LPS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书